» Articles » PMID: 23342375

Neonatal Calf Infection with Respiratory Syncytial Virus: Drawing Parallels to the Disease in Human Infants

Overview
Journal Viruses
Publisher MDPI
Specialty Microbiology
Date 2013 Jan 25
PMID 23342375
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Respiratory syncytial virus (RSV) is the most common viral cause of childhood acute lower respiratory tract infections. It is estimated that RSV infections result in more than 100,000 deaths annually worldwide. Bovine RSV is a cause of enzootic pneumonia in young dairy calves and summer pneumonia in nursing beef calves. Furthermore, bovine RSV plays a significant role in bovine respiratory disease complex, the most prevalent cause of morbidity and mortality among feedlot cattle. Infection of calves with bovine RSV shares features in common with RSV infection in children, such as an age-dependent susceptibility. In addition, comparable microscopic lesions consisting of bronchiolar neutrophilic infiltrates, epithelial cell necrosis, and syncytial cell formation are observed. Further, our studies have shown an upregulation of pro-inflammatory mediators in RSV-infected calves, including IL-12p40 and CXCL8 (IL-8). This finding is consistent with increased levels of IL-8 observed in children with RSV bronchiolitis. Since rodents lack IL-8, neonatal calves can be useful for studies of IL-8 regulation in response to RSV infection. We have recently found that vitamin D in milk replacer diets can be manipulated to produce calves differing in circulating 25-hydroxyvitamin D3. The results to date indicate that although the vitamin D intracrine pathway is activated during RSV infection, pro-inflammatory mediators frequently inhibited by the vitamin D intacrine pathway in vitro are, in fact, upregulated or unaffected in lungs of infected calves. This review will summarize available data that provide parallels between bovine RSV infection in neonatal calves and human RSV in infants.

Citing Articles

Immunization with a mucosal, post-fusion F/G protein-based polyanhydride nanovaccine protects neonatal calves against BRSV infection.

Maina T, Grego E, Broderick S, Sacco R, Narasimhan B, McGill J Front Immunol. 2023; 14:1186184.

PMID: 37359514 PMC: 10289034. DOI: 10.3389/fimmu.2023.1186184.


Immune phenotype is differentially affected by changing the type of bovine respiratory disease vaccine administered at revaccination in beef heifers.

Reddout C, Hernandez L, Chase C, Beck P, White F, Salak-Johnson J Front Vet Sci. 2023; 10:1161902.

PMID: 37138923 PMC: 10149669. DOI: 10.3389/fvets.2023.1161902.


Identification of a DRB3*011:01-restricted CD4 T cell response against bovine respiratory syncytial virus fusion protein.

Kaplan B, Hofstetter A, McGill J, Lippolis J, Norimine J, Dassanayake R Front Immunol. 2023; 14:1040075.

PMID: 36891302 PMC: 9986546. DOI: 10.3389/fimmu.2023.1040075.


Validating a bovine model for lung ultrasound of bronchiolitis.

Walsh P, Chaigneau F, Lebedev M, Mutua V, McEligot H, Lam S J Ultrasound. 2022; 25(3):611-624.

PMID: 35067896 PMC: 8784226. DOI: 10.1007/s40477-021-00635-2.


A randomized controlled trial comparing non-steroidal anti-inflammatory and fusion protein inhibitors singly and in combination on the histopathology of bovine respiratory syncytial virus infection.

Chaigneau F, Walsh P, Lebedev M, Mutua V, McEligot H, Bang H PLoS One. 2021; 16(6):e0252455.

PMID: 34111152 PMC: 8191941. DOI: 10.1371/journal.pone.0252455.


References
1.
Gershwin L, Gunther R, Hornof W, Larson R . Effect of infection with bovine respiratory syncytial virus on pulmonary clearance of an inhaled antigen in calves. Am J Vet Res. 2008; 69(3):416-22. DOI: 10.2460/ajvr.69.3.416. View

2.
Karron R, Wright P, Belshe R, Thumar B, Casey R, Newman F . Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants. J Infect Dis. 2005; 191(7):1093-104. DOI: 10.1086/427813. View

3.
Rodrigo Mora J, Iwata M, von Andrian U . Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol. 2009; 8(9):685-98. PMC: 2906676. DOI: 10.1038/nri2378. View

4.
Bartz H, Turkel O, Hoffjan S, Rothoeft T, Gonschorek A, Schauer U . Respiratory syncytial virus decreases the capacity of myeloid dendritic cells to induce interferon-gamma in naïve T cells. Immunology. 2003; 109(1):49-57. PMC: 1782940. DOI: 10.1046/j.1365-2567.2003.01629.x. View

5.
Luongo C, Winter C, Collins P, Buchholz U . Increased genetic and phenotypic stability of a promising live-attenuated respiratory syncytial virus vaccine candidate by reverse genetics. J Virol. 2012; 86(19):10792-804. PMC: 3457269. DOI: 10.1128/JVI.01227-12. View